knowledge -WSS

knowledge

author：comprehensive 2025-09-30 21:40:46 - browse：373

Smartphone & medicine illustration — Alex Hogan/STAT

Pear Therapeutics may be gone, but one of its most important deals is still driving critical conversations about how medical apps can find a foothold in the slow-moving health care system.

In recent months, representatives of the Massachusetts state Medicaid program, MassHealth, have been presenting data suggesting reSET and reSET-O, Pear’s prescription apps that treat substance use disorder and opioid use disorder, saved the state money over a one-year period from 2021 to 2022. The data, which take into account health care utilization before and after people used the apps, have been presented to policymakers considering how to cover novel digital health products and shown to lawmakers considering federal legislation that would require Medicare coverage for prescription apps.

Pear, which filed for bankruptcy earlier this year, was one of the leading companies marketing prescription digital therapeutics, or Food and Drug Administration-cleared apps designed to treat disease. Pear’s reSET was the first such app cleared by the FDA in 2017.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Crinetics acromegaly drug succeeds in late

Wikipedia

WSS

What to know about Virgin Galactic's 1st mission taking paying customers to space

Amazon on where the company's health care bets are headed next

'Make People Better': The CRISPR babies story you probably don't know

Ethical issues complicate the benefits of medical crowdfunding

Covid hospitalizations on the rise, Humana says

Friends ask where James Watson's attitudes about race came from

focus

knowledge

knowledge

Novavax promises a turnaround & Lilly roils the obesity market

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

Virginia high school admissions case could be legal follow

Stem cell treatment guidelines are released by FDA

Medical leaders decry Supreme Court decision on affirmative action

Stem cell treatment guidelines are released by FDA

Bright Health sells Medicare Advantage business to Molina

Man killed during FBI raid in connection with threats against Biden, other officials

The cancer drug shortage isn’t new — and neither are the solutions

'Make People Better': The CRISPR babies story you probably don't know

knowledge

Medicaid rebukes states for mistakenly disenrolling children

What drug price negotiations mean for Medicare Part D

How to fix cancer clinical trials' diversity problem

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

A new House health package & hospitals’ new site

Stem cell treatment guidelines are released by FDA

leisure time

Wikipedia

leisure time

hotspot